

Delphi Quantitative Sciences specializes data analytical aspects of clinical pharmacology and DMPK. Particularly, we have a passionate focus on PK/PD modeling and simulation, pharmacometric analyses, data programming and non-compartmental PK data analysis. We offer solutions from preclinical-to-clinical translation and dose selection for clinical studies through quantitative approaches. Our staff is well-versed in the areas of PK/PD, population-based PK/PD modeling as well as traditional NCA analysis. We also provide general clinical pharmacology support such as writing PK-related sections of the CSR, IND, IB, NDA/BLA and TK reports. We have experience working in many disease areas including Analgesia, Cardiovascular, CNS, Dermatology, Gastrointestinal, Infectious Diseases, Oncology, Orphan Disease, Pulmonary, Rheumatology. Contact us today for a highly competitive quote!
- Population PK Analysis
- Dose Selection
- Trial Simulations
- Exposure-Response (ER) Analysis
- Exposure-QT Analysis
- Mechanistic Modeling
- Noncompartmental Analysis (NCA)
- Toxicokinetic Analysis
- Submission-Ready Study Reports
- Protocol writing
- CSR PK/TK sections
- IND sections
- IB sections
- NDA/BLA sections
- We are open to discussion regarding relevant services not listed here
- We have in-depth experience supporting nonclinical/toxicology work as well